pISSN 2508-6235 eISSN 2508-7576

Table. 1.

Commonly used products for weight reduction

Drug*Short- or long-termAction mechanismClassification by US Controlled Substances Act
OrlistatLong-termA reversible gastric and pancreatic lipase inhibitor that reduces the absorption of dietary fatNot a controlled substance
PhentermineShort-termSympathomimetic amineSchedule IV
DiethylpropionShort-termSympathomimetic amineSchedule IV
MazindolShort-termSympathomimetic amineNot available in US
Phentermine/topiramate (Qsymia?)Long-termSympathomimetic amine/antiepileptic drugSchedule IV
Lorcaserin (Belviq?)Long-term5-HT2c receptor agonistSchedule IV
Naltrexone/bupropion (Contrave?)Long-termOpioid antagonist/anti-depressantNot a controlled substance
Liraglutide (Victoza?)Long-termGLP-1 analogueNot a controlled substance

Short-term therapy is considered as a few weeks, usually up to 12 weeks.

Korean J Obes 2015;24:17~27 https://doi.org/10.7570/kjo.2015.24.1.17